The tumor blood vessel as an ideal target for macromolecular anticancer agents
- 31 March 1992
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 19 (1-3) , 315-324
- https://doi.org/10.1016/0168-3659(92)90086-7
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Review : Synthetic Polymers with Intrinsic Anticancer ActivityJournal of Bioactive and Compatible Polymers, 1991
- Reduced bone marrow toxicity of neocarzinostatin by conjugation with divinyl ether-maleic acid copolymerEuropean Journal of Cancer and Clinical Oncology, 1990
- Protein Binding of Macromolecular Anticancer Agent SMANCS: Characterization of Poly(styrene-co-maleic acid) Derivatives as an Albumin Binding LigandJournal of Bioactive and Compatible Polymers, 1988
- Chemical modification of superoxide dismutase Extension of plasma half life of the enzyme through its reversible binding to the circulating albuminInternational Journal of Peptide and Protein Research, 1988
- Image enhancement in computerized tomography for sensitive diagnosis of liver cancer and semiquantitation of tumor selective drug targeting with oily contrast mediumCancer, 1985
- Selective targeting of anti-cancer drug and simultaneous image enhancement in solid tumors by arterially administered lipid contrast mediumCancer, 1984
- Tailor-making of protein drugs by polymer conjugation for tumor targeting: A brief review on smancsProtein Journal, 1984
- Effect of arterial administration of high-molecular-weight anticancer agent SMANCS with lipid lymphographic agent on hepatoma: a preliminary reportEuropean Journal of Cancer and Clinical Oncology, 1983
- Anti‐tumor activity of daunorubicin linked to poly‐L‐aspartic acidInternational Journal of Cancer, 1982
- Mechanisms of localization of gallium-67 in tumorsSeminars in Nuclear Medicine, 1978